American Journal of Physiology - Endocrinology and Metabolism, ISSN 0193-1849, 06/2017, Volume 312, Issue 6, pp. E495 - E507
Cushing’s syndrome is caused by overproduction of the adrenocorticotropic hormone (ACTH), which stimulates the adrenal grand to make cortisol. Skeletal muscle...
Skeletal muscle atrophy | Cushing’s syndrome | Forkhead box O3 | Glucocorticoid receptor
Skeletal muscle atrophy | Cushing’s syndrome | Forkhead box O3 | Glucocorticoid receptor
Journal Article
American Journal of Physiology - Endocrinology and Metabolism, ISSN 0193-1849, 01/2018, Volume 314, Issue 1, pp. E39 - E52
Cushing’s syndrome (CS) caused by hypercortisolism is occasionally accompanied by metabolic disorders such as hypertension, diabetes mellitus (DM),...
Hypertension | Histone deacetylashyperglycemia | Cushing’s syndrome | Glucocorticoid receptor
Hypertension | Histone deacetylashyperglycemia | Cushing’s syndrome | Glucocorticoid receptor
Journal Article
American Journal of Physiology, ISSN 0193-1849, 06/2017, Volume 312, Issue 6, p. E495
Cushing's syndrome is caused by overproduction of the adrenocorticotropic hormone (ACTH), which stimulates the adrenal grand to make cortisol. Skeletal muscle...
Ubiquitin | Transcription | Glucocorticoids | Hormones | Hydrocortisone | Atrophy | Proteins | Infusion | Rodents | Forkhead protein | FOXO3 protein | Enzymes | Nervous system diseases | Pol II | Dexamethasone | Diabetes mellitus | Muscles | Cushing's syndrome | Skeletal muscle | Musculoskeletal system | Adrenocorticotropic hormone | Pituitary | Weight reduction | Protein expression | Sepsis
Ubiquitin | Transcription | Glucocorticoids | Hormones | Hydrocortisone | Atrophy | Proteins | Infusion | Rodents | Forkhead protein | FOXO3 protein | Enzymes | Nervous system diseases | Pol II | Dexamethasone | Diabetes mellitus | Muscles | Cushing's syndrome | Skeletal muscle | Musculoskeletal system | Adrenocorticotropic hormone | Pituitary | Weight reduction | Protein expression | Sepsis
Journal Article
Journal of Applied Physiology, ISSN 8750-7587, 10/2019
Exercise has positive effects on health and improves a variety of disease conditions. An in vitro model of exercise has been developed to better understand its...
Journal Article
American Journal of Physiology, ISSN 0193-1849, 01/2018, Volume 314, Issue 1, p. E39
Cushing's syndrome (CS) caused by hypercortisolism is occasionally accompanied by metabolic disorders such as hypertension, diabetes mellitus (DM),...
Histone deacetylase | Regulators | Chromatin | Immunoprecipitation | Transcription | Glucocorticoids | Genes | Dyslipidemia | Genomes | Glucose | Blood | Hyperglycemia | Rodents | Pituitary gland | Blood pressure | Inhibition | Acetylation | Gluconeogenesis | Hypertension | Nervous system diseases | Kidneys | Dexamethasone | Diabetes mellitus | Rats | Cushing's syndrome | Gene expression | Patients | Morbidity | Glucose tolerance | Intolerance | Adrenocorticotropic hormone | Pituitary | Cardiovascular diseases | Metabolic disorders
Histone deacetylase | Regulators | Chromatin | Immunoprecipitation | Transcription | Glucocorticoids | Genes | Dyslipidemia | Genomes | Glucose | Blood | Hyperglycemia | Rodents | Pituitary gland | Blood pressure | Inhibition | Acetylation | Gluconeogenesis | Hypertension | Nervous system diseases | Kidneys | Dexamethasone | Diabetes mellitus | Rats | Cushing's syndrome | Gene expression | Patients | Morbidity | Glucose tolerance | Intolerance | Adrenocorticotropic hormone | Pituitary | Cardiovascular diseases | Metabolic disorders
Journal Article
Journal of Pharmacy and Pharmacology, ISSN 0022-3573, 05/2015, Volume 67, Issue 5, pp. 714 - 719
Objectives The aim of this study was to investigate the cardiovascular relaxing properties of monoterpene alcohol (‐)‐linalool (LIN), a principal component of...
K+ channel | (‐)‐linalool | soluble guanylyl cyclase | vasorelaxation | channel | (-)-linalool | Vasorelaxation | Soluble guanylyl cyclase | K + channel | SMOOTH-MUSCLE | POTASSIUM CHANNELS | ESSENTIAL OIL | NITRIC-OXIDE | PHARMACOLOGY & PHARMACY | STRESS | HYPERTENSIVE-RATS | BLOOD-PRESSURE | NG-Nitroarginine Methyl Ester - pharmacology | Tetraethylammonium - pharmacology | Vasodilator Agents - pharmacology | Calcium - metabolism | Aorta - drug effects | Endoplasmic Reticulum - metabolism | Guanylate Cyclase - metabolism | Male | Aorta - metabolism | Enzyme Activation - drug effects | Dose-Response Relationship, Drug | Potassium Channels - metabolism | Quinoxalines - pharmacology | Calcium Chloride - pharmacology | Monoterpenes - pharmacology | Animals | Oxadiazoles - pharmacology | Calcium Chloride - antagonists & inhibitors | Dinoprost - antagonists & inhibitors | Mice | Monoterpenes - antagonists & inhibitors | Vasodilation - drug effects | Dinoprost - pharmacology | Blood vessels | Dilatation | Nitric oxide
K+ channel | (‐)‐linalool | soluble guanylyl cyclase | vasorelaxation | channel | (-)-linalool | Vasorelaxation | Soluble guanylyl cyclase | K + channel | SMOOTH-MUSCLE | POTASSIUM CHANNELS | ESSENTIAL OIL | NITRIC-OXIDE | PHARMACOLOGY & PHARMACY | STRESS | HYPERTENSIVE-RATS | BLOOD-PRESSURE | NG-Nitroarginine Methyl Ester - pharmacology | Tetraethylammonium - pharmacology | Vasodilator Agents - pharmacology | Calcium - metabolism | Aorta - drug effects | Endoplasmic Reticulum - metabolism | Guanylate Cyclase - metabolism | Male | Aorta - metabolism | Enzyme Activation - drug effects | Dose-Response Relationship, Drug | Potassium Channels - metabolism | Quinoxalines - pharmacology | Calcium Chloride - pharmacology | Monoterpenes - pharmacology | Animals | Oxadiazoles - pharmacology | Calcium Chloride - antagonists & inhibitors | Dinoprost - antagonists & inhibitors | Mice | Monoterpenes - antagonists & inhibitors | Vasodilation - drug effects | Dinoprost - pharmacology | Blood vessels | Dilatation | Nitric oxide
Journal Article
Molecular pharmacology, ISSN 0026-895X, 05/2015, Volume 87, Issue 5, pp. 782 - 791
Inhibition of histone deacetylases (HDACs) by valproic acid (VPA) attenuates inflammatory, hypertrophic, and fibrotic responses in the hearts of spontaneously...
ANDROGEN RECEPTOR | TRANSCRIPTIONAL ACTIVITY | GLUCOCORTICOID-RECEPTOR | HINGE REGION | TRANSACTIVATION | P300 | ALPHA | PHARMACOLOGY & PHARMACY | ANGIOTENSIN-II | ALDOSTERONE | BINDING | Receptors, Mineralocorticoid - genetics | Fibrosis - drug therapy | Gene Expression - drug effects | Gene Expression - genetics | Receptors, Mineralocorticoid - metabolism | Rats, Inbred WKY | Male | RNA Polymerase II - metabolism | Fibrosis - metabolism | Promoter Regions, Genetic - drug effects | Promoter Regions, Genetic - genetics | Chromatin Immunoprecipitation - methods | Rats, Inbred SHR | Fibrosis - genetics | Histone Deacetylases - genetics | Cardiomegaly - drug therapy | Rats | Histone Deacetylases - metabolism | Acetylation - drug effects | Animals | Histones - genetics | Histone Deacetylase Inhibitors - pharmacology | RNA Polymerase II - genetics | Histones - metabolism | Cardiomegaly - genetics | Cardiomegaly - metabolism
ANDROGEN RECEPTOR | TRANSCRIPTIONAL ACTIVITY | GLUCOCORTICOID-RECEPTOR | HINGE REGION | TRANSACTIVATION | P300 | ALPHA | PHARMACOLOGY & PHARMACY | ANGIOTENSIN-II | ALDOSTERONE | BINDING | Receptors, Mineralocorticoid - genetics | Fibrosis - drug therapy | Gene Expression - drug effects | Gene Expression - genetics | Receptors, Mineralocorticoid - metabolism | Rats, Inbred WKY | Male | RNA Polymerase II - metabolism | Fibrosis - metabolism | Promoter Regions, Genetic - drug effects | Promoter Regions, Genetic - genetics | Chromatin Immunoprecipitation - methods | Rats, Inbred SHR | Fibrosis - genetics | Histone Deacetylases - genetics | Cardiomegaly - drug therapy | Rats | Histone Deacetylases - metabolism | Acetylation - drug effects | Animals | Histones - genetics | Histone Deacetylase Inhibitors - pharmacology | RNA Polymerase II - genetics | Histones - metabolism | Cardiomegaly - genetics | Cardiomegaly - metabolism
Journal Article
Clinical and Experimental Pharmacology and Physiology, ISSN 0305-1870, 10/2016, Volume 43, Issue 10, pp. 995 - 1003
A mutation in the mineralocorticoid receptor (MR sub(S) sub(810L)) leads to early-onset hypertension, which is markedly exacerbated during pregnancy. The...
Journal Article
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, ISSN 0193-1849, 01/2018, Volume 314, Issue 1, pp. E39 - E52
Cushing's syndrome (CS) caused by hypercortisolism is occasionally accompanied by metabolic disorders such as hypertension, diabetes mellitus (DM),...
glucocorticoid receptor | TRANSCRIPTIONAL ACTIVITY | SODIUM | PHYSIOLOGY | REDUCES INSULIN-RESISTANCE | TYPE-2 DIABETIC-RAT | HDAC INHIBITION | Cushing's syndrome | VALPROIC ACID | GLUCOCORTICOID RESPONSE ELEMENT | histone deacetylase | MINERALOCORTICOID RECEPTOR | hyperglycemia | GLUCOSE-HOMEOSTASIS | GENE | ENDOCRINOLOGY & METABOLISM | hypertension | Hyperglycemia - prevention & control | Cushing Syndrome - physiopathology | Humans | Hyperglycemia - complications | Rats | Male | Rats, Sprague-Dawley | Hypertension - physiopathology | Blood Glucose - drug effects | Hypertension - blood | Animals | Cushing Syndrome - pathology | Hyperglycemia - blood | HEK293 Cells | Hypertension - complications | Hypertension - prevention & control | Cushing Syndrome - blood | Histone Deacetylase Inhibitors - pharmacology | Blood Pressure - drug effects | Histone Deacetylase Inhibitors - therapeutic use | Blood Glucose - metabolism | Hyperglycemia - physiopathology | Cushing Syndrome - drug therapy | Disease Models, Animal
glucocorticoid receptor | TRANSCRIPTIONAL ACTIVITY | SODIUM | PHYSIOLOGY | REDUCES INSULIN-RESISTANCE | TYPE-2 DIABETIC-RAT | HDAC INHIBITION | Cushing's syndrome | VALPROIC ACID | GLUCOCORTICOID RESPONSE ELEMENT | histone deacetylase | MINERALOCORTICOID RECEPTOR | hyperglycemia | GLUCOSE-HOMEOSTASIS | GENE | ENDOCRINOLOGY & METABOLISM | hypertension | Hyperglycemia - prevention & control | Cushing Syndrome - physiopathology | Humans | Hyperglycemia - complications | Rats | Male | Rats, Sprague-Dawley | Hypertension - physiopathology | Blood Glucose - drug effects | Hypertension - blood | Animals | Cushing Syndrome - pathology | Hyperglycemia - blood | HEK293 Cells | Hypertension - complications | Hypertension - prevention & control | Cushing Syndrome - blood | Histone Deacetylase Inhibitors - pharmacology | Blood Pressure - drug effects | Histone Deacetylase Inhibitors - therapeutic use | Blood Glucose - metabolism | Hyperglycemia - physiopathology | Cushing Syndrome - drug therapy | Disease Models, Animal
Journal Article
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, ISSN 0193-1849, 06/2017, Volume 312, Issue 6, pp. E495 - E507
Cushing's syndrome is caused by overproduction of the adrenocorticotropic hormone (ACTH), which stimulates the adrenal grand to make cortisol. Skeletal muscle...
glucocorticoid receptor | PHYSIOLOGY | PROTEIN | ANTAGONIST | skeletal muscle atrophy | COMPONENTS | Cushing's syndrome | AUTOPHAGY | FOXO TRANSCRIPTION FACTORS | HYPERTROPHY | GLUCOCORTICOID-RECEPTOR | ENDOCRINOLOGY & METABOLISM | GENE-EXPRESSION | forkhead box O3 | CROSSTALK | UP-REGULATION | Receptors, Glucocorticoid - antagonists & inhibitors | Cushing Syndrome - physiopathology | SKP Cullin F-Box Protein Ligases - genetics | Ubiquitin-Protein Ligases - antagonists & inhibitors | Male | Muscle, Skeletal - metabolism | Receptors, Glucocorticoid - metabolism | Muscle Fibers, Skeletal - drug effects | Muscle Fibers, Skeletal - metabolism | Cushing Syndrome - metabolism | Promoter Regions, Genetic - drug effects | Receptors, Glucocorticoid - agonists | Forkhead Box Protein O3 - genetics | Chromatin Immunoprecipitation | Cushing Syndrome - pathology | RNA Interference | Muscle, Skeletal - drug effects | Muscle Proteins - metabolism | Forkhead Box Protein O3 - antagonists & inhibitors | Muscle Proteins - antagonists & inhibitors | Muscular Atrophy - etiology | Disease Models, Animal | Cell Line | Tripartite Motif Proteins - antagonists & inhibitors | Ubiquitin-Protein Ligases - metabolism | Tripartite Motif Proteins - agonists | Tripartite Motif Proteins - genetics | SKP Cullin F-Box Protein Ligases - metabolism | SKP Cullin F-Box Protein Ligases - antagonists & inhibitors | Rats, Sprague-Dawley | Forkhead Box Protein O3 - metabolism | Hormone Antagonists - pharmacology | Forkhead Box Protein O3 - agonists | Gene Expression Regulation - drug effects | Muscle Proteins - genetics | Response Elements - drug effects | Muscle Proteins - agonists | Animals | Active Transport, Cell Nucleus - drug effects | Muscle Fibers, Skeletal - pathology | Glucocorticoids - pharmacology | Genes, Reporter - drug effects | Tripartite Motif Proteins - metabolism | Muscle, Skeletal - pathology | Ubiquitin-Protein Ligases - genetics | Muscles | Physiological aspects | Atrophy, Muscular | Cushing syndrome
glucocorticoid receptor | PHYSIOLOGY | PROTEIN | ANTAGONIST | skeletal muscle atrophy | COMPONENTS | Cushing's syndrome | AUTOPHAGY | FOXO TRANSCRIPTION FACTORS | HYPERTROPHY | GLUCOCORTICOID-RECEPTOR | ENDOCRINOLOGY & METABOLISM | GENE-EXPRESSION | forkhead box O3 | CROSSTALK | UP-REGULATION | Receptors, Glucocorticoid - antagonists & inhibitors | Cushing Syndrome - physiopathology | SKP Cullin F-Box Protein Ligases - genetics | Ubiquitin-Protein Ligases - antagonists & inhibitors | Male | Muscle, Skeletal - metabolism | Receptors, Glucocorticoid - metabolism | Muscle Fibers, Skeletal - drug effects | Muscle Fibers, Skeletal - metabolism | Cushing Syndrome - metabolism | Promoter Regions, Genetic - drug effects | Receptors, Glucocorticoid - agonists | Forkhead Box Protein O3 - genetics | Chromatin Immunoprecipitation | Cushing Syndrome - pathology | RNA Interference | Muscle, Skeletal - drug effects | Muscle Proteins - metabolism | Forkhead Box Protein O3 - antagonists & inhibitors | Muscle Proteins - antagonists & inhibitors | Muscular Atrophy - etiology | Disease Models, Animal | Cell Line | Tripartite Motif Proteins - antagonists & inhibitors | Ubiquitin-Protein Ligases - metabolism | Tripartite Motif Proteins - agonists | Tripartite Motif Proteins - genetics | SKP Cullin F-Box Protein Ligases - metabolism | SKP Cullin F-Box Protein Ligases - antagonists & inhibitors | Rats, Sprague-Dawley | Forkhead Box Protein O3 - metabolism | Hormone Antagonists - pharmacology | Forkhead Box Protein O3 - agonists | Gene Expression Regulation - drug effects | Muscle Proteins - genetics | Response Elements - drug effects | Muscle Proteins - agonists | Animals | Active Transport, Cell Nucleus - drug effects | Muscle Fibers, Skeletal - pathology | Glucocorticoids - pharmacology | Genes, Reporter - drug effects | Tripartite Motif Proteins - metabolism | Muscle, Skeletal - pathology | Ubiquitin-Protein Ligases - genetics | Muscles | Physiological aspects | Atrophy, Muscular | Cushing syndrome
Journal Article
BMC Neurology, ISSN 1471-2377, 02/2016, Volume 16, Issue 1, p. 17
Background: Carpal tunnel syndrome (CTS) is a common peripheral neuropathy and ischemic-reperfusion injury. Oxidative stress is considered a major cause of...
Carpal tunnel syndrome | Antioxidative activity | Linalool | OXIDATIVE STRESS | INFLAMMATION | RATS | MICE | CLINICAL NEUROLOGY | Double-Blind Method | Humans | Middle Aged | Administration, Inhalation | Male | Heart Rate - drug effects | Antioxidants - therapeutic use | Adult | Female | Aged | Blood Pressure - drug effects | Carpal Tunnel Syndrome - drug therapy | Monoterpenes - therapeutic use | Antioxidants | Complications and side effects | Care and treatment | Reactive oxygen species | Influence | Research
Carpal tunnel syndrome | Antioxidative activity | Linalool | OXIDATIVE STRESS | INFLAMMATION | RATS | MICE | CLINICAL NEUROLOGY | Double-Blind Method | Humans | Middle Aged | Administration, Inhalation | Male | Heart Rate - drug effects | Antioxidants - therapeutic use | Adult | Female | Aged | Blood Pressure - drug effects | Carpal Tunnel Syndrome - drug therapy | Monoterpenes - therapeutic use | Antioxidants | Complications and side effects | Care and treatment | Reactive oxygen species | Influence | Research
Journal Article
The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology, ISSN 0372-1582, 2018, Volume 22, Issue 1, pp. 23 - 33
Cushing's syndrome (CS) is a collection of symptoms caused by prolonged exposure to excess cortisol. Chronically elevated glucocorticoid (GC) levels contribute...
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 12/2015, Volume 769, pp. 48 - 54
Clinical studies have shown that the use of combined oral contraceptive in pre-menopausal women is associated with fluid retention. However, the molecular...
Oral contraceptive | Mineralocorticoid receptor | Histone code | Gene transcription | SYSTEM | TRANSCRIPTIONAL ACTIVITY | HEART-FAILURE | RATS | BLOOD-PRESSURE | DROSPIRENONE | PHARMACOLOGY & PHARMACY | ALDOSTERONE | ETHINYLESTRADIOL | BLOCKADE | FLUID-RELATED SYMPTOMS | Kidney Cortex - drug effects | Kidney Cortex - metabolism | Receptors, Mineralocorticoid - metabolism | Protein-Serine-Threonine Kinases - genetics | Rats | Norgestrel - pharmacology | Protein Transport - drug effects | RNA Polymerase II - metabolism | Transcription Factors - genetics | Ethinyl Estradiol - pharmacology | Promoter Regions, Genetic - drug effects | Rats, Sprague-Dawley | Drug Synergism | Gene Expression Regulation - drug effects | Animals | Immediate-Early Proteins - genetics | Histone Code - drug effects | Base Sequence | Contraceptives, Oral, Combined - pharmacology | Female | Receptors, Mineralocorticoid - chemistry | Norgestrel | Medical colleges | Corticosteroids | RNA | Analysis | Histones | Ethinyl estradiol | Oral contraceptives | Adenosine triphosphatase | Steroids
Oral contraceptive | Mineralocorticoid receptor | Histone code | Gene transcription | SYSTEM | TRANSCRIPTIONAL ACTIVITY | HEART-FAILURE | RATS | BLOOD-PRESSURE | DROSPIRENONE | PHARMACOLOGY & PHARMACY | ALDOSTERONE | ETHINYLESTRADIOL | BLOCKADE | FLUID-RELATED SYMPTOMS | Kidney Cortex - drug effects | Kidney Cortex - metabolism | Receptors, Mineralocorticoid - metabolism | Protein-Serine-Threonine Kinases - genetics | Rats | Norgestrel - pharmacology | Protein Transport - drug effects | RNA Polymerase II - metabolism | Transcription Factors - genetics | Ethinyl Estradiol - pharmacology | Promoter Regions, Genetic - drug effects | Rats, Sprague-Dawley | Drug Synergism | Gene Expression Regulation - drug effects | Animals | Immediate-Early Proteins - genetics | Histone Code - drug effects | Base Sequence | Contraceptives, Oral, Combined - pharmacology | Female | Receptors, Mineralocorticoid - chemistry | Norgestrel | Medical colleges | Corticosteroids | RNA | Analysis | Histones | Ethinyl estradiol | Oral contraceptives | Adenosine triphosphatase | Steroids
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2015, Volume 10, Issue 8, p. e0136801
Histone deacetylases (HDACs) act as corepressors in gene transcription by altering the acetylation of histones, resulting in epigenetic gene silencing. We...
PROTEIN-KINASE-A | SYSTEM | LOCALIZATION | ACETYLATION | PHOSPHORYLATION | MULTIDISCIPLINARY SCIENCES | CLASS-I | MUSCLE | ALDOSTERONE | INHIBITORS | CAMP | Cyclic AMP-Dependent Protein Kinases - metabolism | Promoter Regions, Genetic | Receptors, Mineralocorticoid - genetics | Histone Deacetylases - genetics | Receptors, Mineralocorticoid - metabolism | Humans | Phosphoprotein Phosphatases - metabolism | Histone Deacetylase Inhibitors - administration & dosage | Repressor Proteins - genetics | Histone Deacetylases - metabolism | Gene Expression Regulation, Enzymologic | Oxazoles - administration & dosage | Transcription, Genetic | RNA, Small Interfering | Acetylation | Repressor Proteins - metabolism | Epigenetic inheritance | Mineralocorticoids | Genetic transcription | Research | Protein kinase A | Histone deacetylase | Chromatin | Phosphorylation | Transcription factors | Immunoprecipitation | Genes | Aldosterone | Kinases | Phosphatase | DNA-directed RNA polymerase | Proteins | Transcription activation | Histones | Physiology | Calyculin A | Translocation | Pharmacology | siRNA | Gene expression | Nuclear transport | Medicine | Polymerase | Gene silencing | Ribonucleic acids | Lysine | Plasmids | RNA polymerase II
PROTEIN-KINASE-A | SYSTEM | LOCALIZATION | ACETYLATION | PHOSPHORYLATION | MULTIDISCIPLINARY SCIENCES | CLASS-I | MUSCLE | ALDOSTERONE | INHIBITORS | CAMP | Cyclic AMP-Dependent Protein Kinases - metabolism | Promoter Regions, Genetic | Receptors, Mineralocorticoid - genetics | Histone Deacetylases - genetics | Receptors, Mineralocorticoid - metabolism | Humans | Phosphoprotein Phosphatases - metabolism | Histone Deacetylase Inhibitors - administration & dosage | Repressor Proteins - genetics | Histone Deacetylases - metabolism | Gene Expression Regulation, Enzymologic | Oxazoles - administration & dosage | Transcription, Genetic | RNA, Small Interfering | Acetylation | Repressor Proteins - metabolism | Epigenetic inheritance | Mineralocorticoids | Genetic transcription | Research | Protein kinase A | Histone deacetylase | Chromatin | Phosphorylation | Transcription factors | Immunoprecipitation | Genes | Aldosterone | Kinases | Phosphatase | DNA-directed RNA polymerase | Proteins | Transcription activation | Histones | Physiology | Calyculin A | Translocation | Pharmacology | siRNA | Gene expression | Nuclear transport | Medicine | Polymerase | Gene silencing | Ribonucleic acids | Lysine | Plasmids | RNA polymerase II
Journal Article
Dalton Transactions, ISSN 1477-9226, 01/2013, Volume 42, Issue 2, pp. 466 - 475
Sixteen arene-Ru based molecular-rectangles were self-assembled in high yields by the equimolar mixing of arene-Ru acceptors (Aa-Ad) with various azopyridyl...
MOLECULAR-RECTANGLES | MULTI-CARBOXYLATE ANIONS | ANTICANCER ACTIVITY | IN-VITRO | INHIBITION | ARENE COMPLEXES | CANCER-CHEMOTHERAPY | SERUM-ALBUMIN | RUTHENIUM | CELL-DEATH | CHEMISTRY, INORGANIC & NUCLEAR | Chemistry Techniques, Synthetic | Apoptosis - drug effects | Pyridines - chemistry | Antineoplastic Agents - chemical synthesis | Humans | Molecular Conformation | Models, Molecular | Antineoplastic Agents - chemistry | Antineoplastic Agents - metabolism | Azo Compounds - chemistry | Biological Transport | Organometallic Compounds - metabolism | Organometallic Compounds - chemical synthesis | Cell Line, Tumor | Ligands | Organometallic Compounds - chemistry | Antineoplastic Agents - pharmacology | Cell Cycle - drug effects | Organometallic Compounds - pharmacology
MOLECULAR-RECTANGLES | MULTI-CARBOXYLATE ANIONS | ANTICANCER ACTIVITY | IN-VITRO | INHIBITION | ARENE COMPLEXES | CANCER-CHEMOTHERAPY | SERUM-ALBUMIN | RUTHENIUM | CELL-DEATH | CHEMISTRY, INORGANIC & NUCLEAR | Chemistry Techniques, Synthetic | Apoptosis - drug effects | Pyridines - chemistry | Antineoplastic Agents - chemical synthesis | Humans | Molecular Conformation | Models, Molecular | Antineoplastic Agents - chemistry | Antineoplastic Agents - metabolism | Azo Compounds - chemistry | Biological Transport | Organometallic Compounds - metabolism | Organometallic Compounds - chemical synthesis | Cell Line, Tumor | Ligands | Organometallic Compounds - chemistry | Antineoplastic Agents - pharmacology | Cell Cycle - drug effects | Organometallic Compounds - pharmacology
Journal Article
Dalton Transactions, ISSN 1477-9226, 12/2012, Volume 42, Issue 2, pp. 466 - 475
Sixteen arene-Ru based molecular-rectangles were self-assembled in high yields by the equimolar mixing of arene-Ru acceptors (Aa-Ad) with various azopyridyl...
Human | Cellular | Diffraction | Fluorescence | Ligands | Position (location) | Apoptosis | Cancer
Human | Cellular | Diffraction | Fluorescence | Ligands | Position (location) | Apoptosis | Cancer
Journal Article
Journal of Applied Physics, ISSN 0021-8979, 05/2015, Volume 117, Issue 17, p. 173104
We numerically analyze the characteristics of a nanocavity in surface plasmon polariton (SPP) modes confined by total external reflection (TER) at deep...
PHYSICS, APPLIED | PHOTOLUMINESCENCE | LASERS | WAVE-GUIDES | CONFINEMENT | ABSORPTION | SCALE | ZNSE | PROPAGATION | METAL-FILMS | Polaritons | Research | Plasmons (Physics) | Analysis | Photonics
PHYSICS, APPLIED | PHOTOLUMINESCENCE | LASERS | WAVE-GUIDES | CONFINEMENT | ABSORPTION | SCALE | ZNSE | PROPAGATION | METAL-FILMS | Polaritons | Research | Plasmons (Physics) | Analysis | Photonics
Journal Article
Journal of Pharmacy and Pharmacology, ISSN 0022-3573, 05/2013, Volume 65, Issue 5, p. 745
Objectives The aim of this study was to explore the effect of the essential oil of Citrus bergamiaRisso (bergamot) on mouse blood vessels and to analyse the...
Proteins | Rodents | Blood vessels | Endothelium
Proteins | Rodents | Blood vessels | Endothelium
Journal Article
Journal of Neurology, Neurosurgery & Psychiatry, ISSN 0022-3050, 11/2018, Volume 89, Issue 11, pp. 1228 - 1228
The demographic data and clinical characteristics of patients with low BMImin-1yr (<18.5 kg/m2) and normal BMImin-1yr (≥18.5 kg/m2) are shown in table 5 in the...
neuroimmunology | SURGERY | PSYCHIATRY | CLINICAL NEUROLOGY | Studies | Neurology | Body mass index | Immunoglobulins | Statistical analysis | Disease | Womens health | Aquaporins | Rheumatoid arthritis | Mortality | Regression analysis | Age | 1506 | PostScript
neuroimmunology | SURGERY | PSYCHIATRY | CLINICAL NEUROLOGY | Studies | Neurology | Body mass index | Immunoglobulins | Statistical analysis | Disease | Womens health | Aquaporins | Rheumatoid arthritis | Mortality | Regression analysis | Age | 1506 | PostScript
Journal Article
FEBS Letters, ISSN 0014-5793, 12/2007, Volume 581, Issue 30, pp. 5774 - 5780
We recently reported that a histidine (H191) in the S3–S4 loop of domain I is critical for nickel inhibition of the Cav3.2 T‐type Ca2+ channel. As in Cav3.2,...
Cav2.3 channel | Nickel inhibition | S3–S4 loop | Histidine | Voltage clamping | 2.3 channel | S3-S4 loop | Xenopus | Amino Acid Sequence | Cation Transport Proteins - antagonists & inhibitors | Protein Structure, Secondary | Humans | Molecular Sequence Data | Mutant Proteins - metabolism | Structure-Activity Relationship | Histidine - metabolism | Dose-Response Relationship, Drug | Sequence Alignment | Animals | Cation Transport Proteins - metabolism | Mutant Proteins - chemistry | Female | Calcium Channels, R-Type - chemistry | Cation Transport Proteins - chemistry | Nickel - pharmacology | Calcium Channels, R-Type - metabolism | Ion Channel Gating - drug effects
Cav2.3 channel | Nickel inhibition | S3–S4 loop | Histidine | Voltage clamping | 2.3 channel | S3-S4 loop | Xenopus | Amino Acid Sequence | Cation Transport Proteins - antagonists & inhibitors | Protein Structure, Secondary | Humans | Molecular Sequence Data | Mutant Proteins - metabolism | Structure-Activity Relationship | Histidine - metabolism | Dose-Response Relationship, Drug | Sequence Alignment | Animals | Cation Transport Proteins - metabolism | Mutant Proteins - chemistry | Female | Calcium Channels, R-Type - chemistry | Cation Transport Proteins - chemistry | Nickel - pharmacology | Calcium Channels, R-Type - metabolism | Ion Channel Gating - drug effects
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.